Texting your way to better diabetes control? new trial tests SMS gum care reminders.

NCT ID NCT07165171

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether sending SMS reminders and advice to people with type 2 diabetes and gum disease can improve their blood sugar control over two years. 516 adults who recently completed gum disease treatment will be split into two groups: one gets standard follow-up, the other gets text messages with medical info, questions, and appointment reminders. The main goal is to see if the SMS group has lower HbA1c levels, a key measure of blood sugar control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SMS text message reminders and advice
What this could lead to
If it works, this could offer a simple, low-cost way to improve blood sugar control in people with type 2 diabetes and gum disease.
What could go wrong
This is an early-stage trial testing a behavioral intervention, not a drug. The effect may be small or not last, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIODONTAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cabinet libéral

    Saint-Victor-de-Cessieu, 38110, France

  • Centre Hospitalo-Universitaire de Lille

    Lille, 59000, France

  • Centre Hospitalo-Universitaire de Nantes

    Nantes, 44000, France

  • Centre Hospitalo-Universitaire de Rennes

    Rennes, 35000, France

  • Centre Hospitalo-Universitaire de Toulouse

    Toulouse, 31300, France

  • Hospices Civils de Lyon, Centre de Soins Dentaires.

    Lyon, 69007, France

  • Hôpital Charles Foix

    Ivry-sur-Seine, 94200, France

  • Hôpitaux universitaires de Strasbourg

    Strasbourg, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.